Obserwuj
Dra. María Esperanza Ruiz
Dra. María Esperanza Ruiz
Prof. Diseño de Experimentos & Control de Calidad de Medicamentos, Universidad Nacional de La Plata
Zweryfikowany adres z biol.unlp.edu.ar - Strona główna
Tytuł
Cytowane przez
Cytowane przez
Rok
Risks of self-medication practices
ME Ruiz
Current drug safety 5 (4), 315-323, 2010
7252010
Solid lipid nanoparticles for drug delivery: Pharmacological and biopharmaceutical aspects
S Scioli Montoto, G Muraca, ME Ruiz
Frontiers in Molecular Biosciences 7, 319, 2020
5262020
Carbamazepine-loaded solid lipid nanoparticles and nanostructured lipid carriers: Physicochemical characterization and in vitro/in vivo evaluation
SS Montoto, ML Sbaraglini, A Talevi, M Couyoupetrou, M Di Ianni, ...
Colloids and Surfaces B: Biointerfaces 167, 73-81, 2018
1052018
Hybrid Ofloxacin/eugenol co-loaded solid lipid nanoparticles with enhanced and targetable antimicrobial properties
B Rodenak-Kladniew, SS Montoto, ML Sbaraglini, M Di Ianni, ME Ruiz, ...
International journal of pharmaceutics 569, 118575, 2019
632019
Routes of Drug Administration
ME Ruiz, SS Montoto
ADME Processes in Pharmaceutical Sciences, 97-133, 2018
61*2018
Análisis farmacéutico
MG Volonté, P Quiroga
Series: Libros de Cátedra, 2013
412013
Applications of nanosystems to anticancer drug therapy (Part II. Dendrimers, micelles, lipid-based nanosystems)
M E Ruiz, M E Gantner, A Talevi
Recent patents on anti-cancer drug discovery 9 (1), 99-128, 2014
392014
The use of saliva as a biological fluid in relative bioavailability studies: comparison and correlation with plasma results
ME Ruiz, P Conforti, P Fagiolino, MG Volonté
Biopharmaceutics & drug disposition 31 (8‐9), 476-485, 2010
392010
Hybrid inhalable microparticles for dual controlled release of levofloxacin and DNase: physicochemical characterization and in vivo targeted delivery to the lungs
GA Islan, ME Ruiz, JF Morales, ML Sbaraglini, AV Enrique, G Burton, ...
Journal of Materials Chemistry B 5 (17), 3132-3144, 2017
302017
Lipid nanoparticles–Metvan: revealing a novel way to deliver a vanadium compound to bone cancer cells
ML Cacicedo, MC Ruiz, S Scioli-Montoto, ME Ruiz, MA Fernandez, ...
New Journal of Chemistry 43 (45), 17726-17734, 2019
292019
Applications of nanosystems to anticancer drug therapy (part I. nanogels, nanospheres, nanocapsules)
A Talevi, M E Gantner, M E Ruiz
Recent patents on anti-cancer drug discovery 9 (1), 83-98, 2014
28*2014
Current state and future perspectives in QSAR models to predict blood-brain barrier penetration in central nervous system drug R&D
J F Morales, S Scioli Montoto, P Fagiolino, M E Ruiz
Mini reviews in medicinal chemistry 17 (3), 247-257, 2017
262017
Korsmeyer-Peppas, Peppas-Sahlin, and Brazel-Peppas: Models of Drug Release
A Talevi, ME Ruiz
The ADME Encyclopedia: A Comprehensive Guide on Biopharmacy and …, 2022
242022
Biopharmaceutical relevance of dissolution profile comparison: proposal of a combined approach
ME Ruiz, MG Volonté
Dissolut Technol 21, 32-43, 2014
23*2014
Baker-Lonsdale model of drug release
A Talevi, ME Ruiz
The ADME Encyclopedia: A Comprehensive Guide on Biopharmacy and …, 2022
212022
A derivative UV spectrophotometric method for the determination of levothyroxine sodium in tablets
A Gregorini, ME Ruiz, MG Volonté
Journal of Analytical Chemistry 68, 510-515, 2013
192013
Development of conformation independent computational models for the early recognition of breast cancer resistance protein substrates
ME Gantner, ME Di Ianni, ME Ruiz, A Talevi, LE Bruno-Blanch
BioMed research international 2013, 2013
192013
Development and validation of a computational model ensemble for the early detection of BCRP/ABCG2 substrates during the drug design stage
ME Gantner, RN Peroni, JF Morales, ML Villalba, ME Ruiz, A Talevi
Journal of chemical information and modeling 57 (8), 1868-1880, 2017
172017
Dissolution studies of generic medications: new evidence of deviations from the transitivity principle
ME Ruiz, A Gregorini, A Talevi, MG Volonté
Dissolution Technologies 19 (1), 13-25, 2012
172012
Procesos biofarmacéuticos: su relación con el diseño de formas farmacéuticas y el éxito de la farmacoterapia
A Talevi, P Quiroga, ME Ruiz
162016
Nie można teraz wykonać tej operacji. Spróbuj ponownie później.
Prace 1–20